Australia Online Health Product Advertising Rules for Importers

The Therapeutic Goods Advertising Code (TGAC) 2021, issued under Section 42BAA of the Therapeutic Goods Act 1989, is the primary regulatory framework governing all advertising of therapeutic goods in Australia, including online advertising, social media, email marketing, and website content. The TGAC applies to any business advertising therapeutic goods to Australian consumers regardless of where the advertiser is physically located. Taiwan brands with ARTG-listed products that run Google Ads, Facebook Ads, or publish marketing content targeting Australian audiences must comply with the TGAC for all that content. The TGA enforces the TGAC through complaints-based investigation and proactive monitoring of online health product advertising, with the power to compel removal of non-compliant advertising and impose civil penalties.

The fundamental principle of the TGAC is that therapeutic goods advertising must be "truthful, balanced and not misleading." Section 10 of the TGAC specifies that advertisements must not make claims that cannot be substantiated by current scientific evidence, create false impressions about product efficacy, use testimonials that misrepresent consumer outcomes, or use fear-based or alarmist language to drive purchases. For AUST L listed medicines, claims are restricted to the approved indications listed in the ARTG entry: you cannot advertise a claim that was not included in your ARTG listing, even if you believe it is scientifically supportable. The TGAC also prohibits comparative advertising that disparages competitor products or implies superior efficacy without head-to-head clinical evidence.

Social media advertising of therapeutic goods is subject to the TGAC in the same way as traditional media. A Facebook post, Instagram story, TikTok video, or YouTube ad for an ARTG-listed product must include the AUST L number (or AUST R number for registered medicines), the sponsor's name, a standard acceptable use statement (such as "Always read the label. Follow the directions for use. Supplements should not replace a balanced diet."), and must not make prohibited claims. TGA has issued enforcement notices to several Australian social media influencers and their brand partners for failing to include required disclosures and for making therapeutic claims not approved in the relevant ARTG listing. For video advertising, the required statements must be clearly legible on screen for a minimum of 4 seconds.

The TGAC prohibition on endorsements from healthcare professionals is one of its most counterintuitive rules for Taiwan brands experienced in marketing health products in other markets. Section 18 of the TGAC prohibits the use of endorsements, recommendations, or testimonials by healthcare professionals (including doctors, pharmacists, naturopaths, and dietitians) in advertising for therapeutic goods directed to consumers. This means a pharmacist or doctor cannot be shown recommending your supplement product in a consumer-facing advertisement. The exception is advertising directed exclusively to healthcare professionals (in medical journals, at pharmacy trade events, or in healthcare professional portals) where regulatory disclosure rules differ. Structure your Australian consumer marketing to use consumer testimonials (from verified purchasers) rather than healthcare professional endorsements.

The Australian Competition and Consumer Commission (ACCC) enforces the Australian Consumer Law (ACL), which applies to all advertising and marketing conduct in Australia, including for health products. Under ACL Section 18, businesses must not engage in "misleading or deceptive conduct" in advertising, and under Sections 29 and 33, they must not make false or misleading representations about goods including their characteristics, ingredients, performance, or benefits. For health product advertisers, the ACCC's Digital Platforms and Industry Conduct Branch actively monitors online advertising and has issued infringement notices to health product advertisers for: claiming products are "clinically proven" without referencing the specific clinical evidence, using before-and-after imagery that implies outcomes beyond those supported by the ARTG listing, and using "natural" or "organic" claims without defining what those terms mean in the context of the specific product.

Online endorsements and reviews are regulated under both the TGAC and the ACL. The ACCC's Guides to Social Media and Influencer Marketing (updated in 2024) require that any payment, free product, commission, or other material benefit received by a person in exchange for a review or endorsement must be disclosed. The required disclosure must be "prominent, clear and upfront" and must appear before the consumer engages with the content (not buried in hashtags or at the end of a long post). Accepted disclosure phrases include "#ad," "#paid partnership," "#gifted," or "I was paid to review this product." The ACCC investigates disclosure failures and has pursued enforcement actions against Australian influencers with penalties of AUD 10,000 to AUD 50,000 per violation under the ACL. Taiwan brands using Australian influencer marketing must include mandatory disclosure language in their influencer briefing contracts.

Subscription and auto-renewal advertising for health products is subject to additional ACCC scrutiny under the ACL's unfair contract terms provisions. If your Australian health product website offers a subscription with automatic renewal, the subscription terms must be disclosed prominently before purchase, with the auto-renewal price, cancellation procedure, and minimum subscription period clearly stated. The ACCC has issued warnings to subscription health product advertisers who buried auto-renewal terms in small print or used pre-ticked opt-in checkboxes for subscription enrollment. Redesign your Australian subscription offer to display the auto-renewal terms in a separate, prominent box adjacent to the "subscribe" button, with the cancellation policy and contact details clearly listed.

Google Ads and Meta Ads policy for Australian health products overlay additional restrictions on top of the TGA and ACCC frameworks. Google's Healthcare and Medicines policy (updated for Australia in 2024) requires that Google Ads for therapeutic goods in Australia display the AUST L or AUST R number in the ad creative, links to the advertiser's Australian website (not a Taiwan or international website), and comply with the TGAC. Meta's advertising policy for health and wellness in Australia prohibits before-and-after imagery for weight loss or medical procedures, claims about treating or curing specific diseases, and subscription health products without clear auto-renewal disclosures. Non-compliant Google or Meta ads are rejected or removed, and repeated violations result in account suspension. Conduct a TGA-TGAC compliance review of all Australian digital ad creative before activating campaigns.

Australia's influencer marketing regulatory framework for health products operates under three overlapping authorities: the TGA (for therapeutic goods advertising compliance), the ACCC (for disclosure of commercial relationships and misleading conduct), and the Australian Association of National Advertisers (AANA) Code of Ethics (for broader advertising standards including targeting of vulnerable audiences). Taiwan brands running Australian influencer campaigns must brief their influencers on all three frameworks. The AANA Code Section 2.7 specifically prohibits advertising health or beauty products in a way that "suggests that a person's physical characteristics, capabilities, or appearance are inferior or if they are likely to cause unnecessary anxiety to any audience member, especially children and young people."

TGA-specific influencer requirements add complexity to influencer campaign management. Under the TGAC, an influencer who promotes an ARTG-listed product must include the AUST L number, the sponsor name, and the standard acceptable use statement in the post. For Instagram or TikTok short-form content where character limits constrain copy, the TGA accepts linking to a product landing page that contains the required statements as compliant, provided the post itself does not make any therapeutic claims beyond those approved in the ARTG listing. The TGA's Advertising Enquiries service (advertising@tga.gov.au) can review proposed influencer content templates before publication to confirm compliance, which is a no-cost service that significantly reduces compliance risk for Taiwan brands unfamiliar with the TGAC framework.

The ACCC's 2024 Influencer Marketing Investigation found that 81 percent of Australian social media influencer posts promoting health and wellness products failed to adequately disclose commercial relationships. The investigation resulted in 18 formal ACCC compliance notices and 3 enforceable undertakings from Australian influencers and their agency representatives. The consequences for non-disclosure include ACCC infringement notices (AUD 15,000 per notice per post for corporates, AUD 3,000 per notice for individuals), and potential ACL Section 18 proceedings that can result in penalties of up to AUD 50 million for serious misleading conduct involving a company. Include disclosure requirements as explicit contractual obligations in all influencer agreements, with a clause specifying that the influencer bears responsibility for compliance with ACCC disclosure guidelines.

Campaign management tools that Taiwan brands should use for Australian influencer compliance include: XTRIBE or Tribe (Australian influencer platforms that include standard ACCC disclosure in their content brief templates), Creator.co (which includes jurisdiction-specific disclosure requirements), and Grin (which has TGAC-compliant workflow for health and wellness brand campaigns). Legal review of campaign content by an Australian advertising lawyer (AUD 3,000 to AUD 6,000 per campaign for initial review and template development) is advisable for any significant Australian influencer marketing campaign. Once compliant templates are established, ongoing campaign compliance management is primarily a quality control process rather than a legal review process.

The TGA's enforcement toolkit for non-compliant therapeutic goods advertising includes: issuing a Compliance Notice requiring the advertiser to modify or remove non-compliant advertising within a specified timeframe (typically 7 to 21 days), applying to the Federal Court for an injunction to restrain ongoing non-compliant advertising, publishing a non-compliant advertising alert on the TGA website (which is publicly searchable and permanently indexed), and referring matters to the Director of Public Prosecutions for criminal prosecution in serious cases. Civil penalties for contravening the TGAC can reach AUD 1.11 million per offense for companies and AUD 222,000 for individuals. The TGA issued 47 formal compliance notices for online health product advertising in the 12 months to June 2026, of which 15 involved international brands advertising to Australian consumers from overseas websites.

The ACCC's ACL enforcement for misleading health product advertising is separate from and additional to TGA enforcement. The ACCC can pursue court orders for corrective advertising (requiring the advertiser to publish corrections at their own expense in the same media where misleading advertising appeared), pecuniary penalties of up to AUD 50 million or 3 times the benefit obtained from the misleading conduct (whichever is greater), and publication orders naming and shaming the non-compliant advertiser in ACCC media releases and the Australian Competition Tribunal register. The ACCC's 2025 priority areas include health and wellness advertising, online subscription traps, and influencer marketing disclosure, making health product advertising one of the highest-scrutiny categories in Australian consumer law enforcement.

Amazon Australia enforces TGA compliance at the product listing level. For ARTG-category products (any product that could be classified as a therapeutic good), Amazon AU requires the AUST L or AUST R number in the product listing before approval. Amazon AU's health and beauty category team conducts proactive audits of listed health products and removes or suspends listings that contain prohibited therapeutic claims, unlisted health claims, or ARTG numbers that cannot be verified against the TGA public ARTG database. Maintaining a current and compliant Amazon AU product listing requires ongoing ARTG compliance monitoring: if your ARTG listing is suspended or varied by the TGA, your Amazon AU product listing must be updated within 30 days.

Risk management best practices for Taiwan brands advertising health products in Australia include: establishing a regular TGAC compliance review cadence (quarterly review of all Australian marketing content by a TGA-qualified regulatory affairs professional, cost AUD 2,000 to AUD 4,000 per quarter), maintaining an Australian advertising complaints log (required under TGAC for products that receive advertising complaints), implementing a pre-publication review process for any new Australian digital content before activation, and subscribing to the TGA's Advertising Regulatory Update e-newsletter to receive advance notice of regulatory changes. Insurance for advertising liability (covering TGA compliance notices and ACCC infringement notices) is available from specialist media liability insurers at annual premiums of AUD 3,000 to AUD 8,000 for small to mid-sized health product companies.